HUMA Humacyte Inc
Company Analysis
Latest News
🟢 HUMA is trading 8.5% up today on bargain-hunting and a technical rebound after a multi-day slide
HUMA is trading 8.5% higher at $0.76 on a technical rebound and bargain-hunting following a sharp multi-day slide. • The stock recently retreated from above...
🟢 HUMA is trading 7.1% up today on a technical rebound following a multi-day slide
HUMA is trading 7.1% up at $0.75 in pre-market, staging a technical bounce after a sharp multi-day slide from above $1.00 to $0.70. * No fresh...
🟢 HUMA is trading 7.1% up today in a technical rebound after multi-day selloff
HUMA is trading 7.1% up today at $0.75 in pre-market, staging a technical rebound after a sharp multi-day selloff. • The stock is bouncing back after sliding...
🟢 HUMA is trading 7.1% up today after recent multi-day selloff
HUMA is trading at $0.75 (7.1% up) in pre-market as the stock stages a modest recovery following a sharp multi-session decline. * Shares recently dropped from...
🔴 HUMA makes sharp 12.9% drop
HUMA is trading at $0.73, down 12.9% versus the comparison close of $0.84 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 HUMA is trading 7.8% down today as selloff continues after dilutive offering
HUMA is trading 7.8% down at $0.77 as investors continue to react to a recent dilutive stock offering that has extended a multi-day slide. • The company's...
🔴 Humacyte Inc is trading 5% down today after recent dilutive stock offering
Humacyte Inc is trading 5% down at $0.88 as investors continue to react to the company's recently priced public offering of common stock. • The stock has been...
🔴 Humacyte Inc is trading 6.0% down today after recent $50M public offering
• Humacyte Inc. shares are down 6.0% today, continuing a multi-day slide that began in early June. • The decline is influenced by the $50 million public...
🟢 Humacyte Inc is trading 6.3% up today with no clear company-specific catalyst found
Humacyte Inc is trading at $1.03 (+6.31%) in pre-market action despite a lack of company-specific headlines, earnings releases, or regulatory updates. • The...
🔴 Humacyte Inc is trading 6.7% down today as investors take profits and react to its recent $50M public offering
Humacyte Inc is trading at $0.96, down 6.7% today as investors continue to take profits following a recent public offering. • The company recently completed a...
Humacyte to Seek FDA Dialysis Approval, Following Positive Phase 3 Results
Humacyte (Nasdaq: HUMA) plans to file a supplemental Biologics License Application (sBLA) with the FDA in the second half of 2026. The submission seeks to...